Xu, Meng
University of Macau
7 papers on CoChatORCID 0000-0002-6118-9965
Most cited papers
- Verified
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 2,182
- Verified
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Han, D., Liu, J., Chen, C., Dong, L., Liu, Y., Chang, R., Huang, X., Liu, Y., Wang, J., Dougherty, U., et al. (2019) · Nature
Immunotherapy and Immune ResponsesRNA modifications and cancer
Cited by 955
- Verified
N 6 -methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription
Liu, J., Dou, X., Chen, C., Chen, C., Liu, C., Xu, M. M., Zhao, S., Shen, B., Gao, Y., Han, D., et al. (2020) · Science
RNA modifications and cancerRNA regulation and disease
Cited by 709
- Verified
Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies
Xu, M., Feng, T., Liu, B., Qiu, F., Xu, Y., Zhao, Y., & Zheng, Y. (2021) · Theranostics
Extracellular vesicles in diseaseNanoparticle-Based Drug Delivery
Cited by 229
- Verified
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations
Adebayo Michael, A. O., Ko, S., Tao, J., Moghe, A., Yang, H., Xu, M., Russell, J. O., Pradhan-Sundd, T., Liu, S., Singh, S., et al. (2019) · Cell Metabolism
PI3K/AKT/mTOR signaling in cancerWnt/β-catenin signaling in development and cancer
Cited by 155
- Verified
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis
Wang, J., Wang, H., Peters, M., Ding, N., Ribback, S., Utpatel, K., Cigliano, A., Dombrowski, F., Xu, M., Chen, X., et al. (2019) · Journal of Hepatology
Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments
Cited by 87
- Verified
P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy
Jia, Y.-L., Xu, M., Dou, C.-W., Liu, Z.-K., Xue, Y.-M., Yao, B.-W., Ding, L.-L., Tu, K.-S., Zheng, X., & Liu, Q.-G. (2016) · Cell Death & Disease
Autophagy in Disease and TherapyHepatocellular Carcinoma Treatment and Prognosis
Cited by 50
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free